Kymab

0 followers


Kymab is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform ava... Read more

Industries

Employees

51-200

Links


Org chart

Collapse
Allan Bradley
Chief Scientific Officer
Nigel Clark
SVP, Business Development
Jasper Clube
SVP, Intellectual Property & Chief Patent Counsel
David Melvin
VP of Informatics
Richard Williams
Vice President CMC

Board & advisors

Martin Nicklasson
Non-Executive Chair
Erwin Boos
Director
Tan Li
Non-Executive Director
Catherine Moukheibir
Non-Executive Director
Timothy Wells
Non-Executive Director
Simone Song
Non-Executive Director
Timothy J Rink
Non-Executive Director
Christian Itin
Non-Executive Director
David Chiswell
Scientific Advisor
Mark Smyth
Advisor